These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 26839493)

  • 1. Notice of Retraction: Pak CS, et al. A Phase III, Randomized, Double-Blind, Matched-Pairs, Active-Controlled Clinical Trial and Preclinical Animal Study to Compare the Durability, Efficacy and Safety between Polynucleotide Filler and Hyaluronic Acid Filler in the Correction of Crow's Feet: A New Concept of Regenerative Filler. J Korean Med Sci 2014; 29(Suppl 3): S201-S209.
    J Korean Med Sci; 2016 Feb; 31(2):330. PubMed ID: 26839493
    [No Abstract]   [Full Text] [Related]  

  • 2. A phase III, randomized, double-blind, matched-pairs, active-controlled clinical trial and preclinical animal study to compare the durability, efficacy and safety between polynucleotide filler and hyaluronic acid filler in the correction of crow's feet: a new concept of regenerative filler.
    Pak CS; Lee J; Lee H; Jeong J; Kim EH; Jeong J; Choi H; Kim B; Oh S; Kim I; Heo CY
    J Korean Med Sci; 2014 Nov; 29 Suppl 3(Suppl 3):S201-9. PubMed ID: 25473210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, patient/evaluator-blinded, split-face study to compare the efficacy and safety of polycaprolactone and polynucleotide fillers in the correction of crow's feet: The latest biostimulatory dermal filler for crow's feet.
    Jeong GJ; Ahn GR; Park SJ; Hong JY; Kim BJ
    J Cosmet Dermatol; 2020 Jul; 19(7):1593-1599. PubMed ID: 31680395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Polynucleotide Dermal Filler in the Correction of Crow's Feet Using an Antera Three-Dimensional Camera.
    Kim JH; Kim ES; Kim SW; Hong SP; Kim J
    Aesthetic Plast Surg; 2022 Aug; 46(4):1902-1909. PubMed ID: 35357558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, Safety, and Subject Satisfaction of PrabotulinumtoxinA for Moderate-to-Severe Crow's Feet: A Phase IV, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.
    Lee SK; Kim MS; Kwon SH; Chung BY; Han SH; Kim HJ
    J Clin Med; 2023 Oct; 12(19):. PubMed ID: 37834970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
    Ascher B; Rzany BJ; Grover R
    Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, Split-Face, Randomized, Long-Term Blinded Objective Comparison of the Performance and Tolerability of Two New Hyaluronic Acid Fillers.
    Trevidic P; Andre P; Benadiba L; Deutsch JJ; Galatoire O; Garcia P; Grand-Vincent A; Boisnic S; Kerihuel JC; Salomon C
    Dermatol Surg; 2017 Dec; 43(12):1448-1457. PubMed ID: 28595250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid microneedle patch for the improvement of crow's feet wrinkles.
    Choi SY; Kwon HJ; Ahn GR; Ko EJ; Yoo KH; Kim BJ; Lee C; Kim D
    Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28892233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Polynucleotide Dermal Filler in the Correction of Crow's Feet Using an Antera Three-Dimensional Camera.
    Casabona G; Kaye K
    Aesthetic Plast Surg; 2022 Aug; 46(4):1910-1912. PubMed ID: 35482064
    [No Abstract]   [Full Text] [Related]  

  • 10. A multicenter, randomized, double-blind clinical study to evaluate the efficacy and safety of a new monophasic hyaluronic acid filler with lidocaine 0.3% in the correction of nasolabial fold.
    Suh JH; Oh CT; Im SI; Lim JS; Kim BJ; Lee JH
    J Cosmet Dermatol; 2017 Sep; 16(3):327-332. PubMed ID: 28145073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
    Beer KR; Julius H; Dunn M; Wilson F
    J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective rater- and subject-blinded study comparing the efficacy of incobotulinumtoxinA and onabotulinumtoxinA to treat crow's feet: a clinical crossover evaluation.
    Muti G; Harrington L
    Dermatol Surg; 2015 Jan; 41 Suppl 1():S39-46. PubMed ID: 25548844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and durability of hyaluronic acid fillers for malar enhancement: A prospective, randomized, split-face clinical controlled trial.
    Jeong KH; Gwak MJ; Moon SK; Lee SJ; Shin MK
    J Cosmet Laser Ther; 2018 Jun; 20(3):184-188. PubMed ID: 28135883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two botulinum toxin type A preparations for treating crow's feet: a split-face, double-blind, proof-of-concept study.
    Prager W; Wissmüller E; Kollhorst B; Williams S; Zschocke I
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2155-60. PubMed ID: 21134046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet.
    Lowe NJ; Lask G; Yamauchi P; Moore D
    J Am Acad Dermatol; 2002 Dec; 47(6):834-40. PubMed ID: 12451366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, randomized, double-blind clinical study to evaluate the efficacy and safety of PP-501-B in correction of nasolabial folds.
    Park KY; Ko EJ; Kim BJ; Kim MN; Hong CK; Chang SE; Won CH; Lee YW
    Dermatol Surg; 2015 Jan; 41(1):113-20. PubMed ID: 25521103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and durability of two hyaluronic acid-based fillers in the correction of nasolabial folds: results of a prospective, randomized, double-blind, actively controlled clinical pilot study.
    Nast A; Reytan N; Hartmann V; Pathirana D; Bachmann F; Erdmann R; Rzany B
    Dermatol Surg; 2011 Jun; 37(6):768-75. PubMed ID: 21605236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel, volumizing cosmetic formulation significantly improves the appearance of target Glabellar lines, nasolabial folds, and crow's feet in a double-blind, vehicle-controlled clinical trial.
    Farris PK; Edison BL; Weinkauf RL; Green BA
    J Drugs Dermatol; 2014 Jan; 13(1):41-6. PubMed ID: 24385118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Clinical Efficacy of Abobotulinumtoxin A (ABO) and Onabotulinumtoxin A (ONA) in the Treatment of Crow's Feet Wrinkles: A Split-Face Study.
    Elridy AS; Zaki RGE; Elshinawy RF
    Semin Ophthalmol; 2018; 33(6):739-747. PubMed ID: 29278961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of highly concentrated hyaluronic acid filler on nasolabial fold correction: A 24-month extension study.
    Noh TK; Moon HR; Yu JS; Chang SE; Moon IJ; Choi SY; Oh WJ; Won CH; Kim BJ; Lee YW
    J Dermatolog Treat; 2016 Nov; 27(6):510-514. PubMed ID: 27121901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.